Samlyn Capital’s Seagen Inc. Common Stock SGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-770,764
Closed -$136M 111
2022
Q2
$136M Buy
770,764
+2,200
+0.3% +$317K 2.73% 10
2022
Q1
$111M Buy
768,564
+219,941
+40% +$29.8M 1.59% 22
2021
Q4
$84.8M Buy
548,623
+83,763
+18% +$14M 1.17% 29
2021
Q3
$78.9M Buy
464,860
+206,277
+80% +$32.1M 1.06% 26
2021
Q2
$40.8M Buy
+258,583
New +$38.4M 0.6% 49
2020
Q3
Sell
-130,450
Closed -$22.2M 178
2020
Q2
$22.2M Sell
130,450
-457,173
-78% -$68.2M 0.41% 70
2020
Q1
$67.8M Buy
587,623
+396,394
+207% +$43.9M 1.71% 24
2019
Q4
$21.9M Buy
+191,229
New +$20.3M 0.46% 59

Other funds holding SGEN

Samlyn Capital's SGEN Position: Q3 2022 in Review

Samlyn Capital sold out of Seagen Inc. Common Stock (SGEN) in Q3 2022, closing a stake of 770,764 shares — an estimated $136M sold.

Samlyn Capital first reported a position in SGEN in Q4 2019 and held it in 8 quarters. The position peaked at $136M in Q2 2022. 539 funds tracked by Wall St. Rank hold SGEN as of Q3 2022.

  • Samlyn Capital reported no remaining Seagen Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
  • Samlyn Capital sold 770,764 Seagen Inc. Common Stock shares in Q3 2022, an estimated $136M.
  • Samlyn Capital first reported a position in Seagen Inc. Common Stock in Q4 2019 and held it in 8 quarters.
  • Samlyn Capital's Seagen Inc. Common Stock position peaked at $136M in Q2 2022.
  • 539 funds tracked by Wall St. Rank held Seagen Inc. Common Stock as of Q3 2022.

Based on Samlyn Capital's 13F filing for Q3 2022, filed 14 Nov 2022.